MétaCan
Menu
Back to cohort
Record W2967876588 · doi:10.1161/atvb.39.suppl_1.114

Abstract 114: Apolipoprotein(a) Secretion is Modulated by Sortilin, Proprotein Convertase Subtilisin/Kexin Type 9, and Microsomal Triglyceride Transfer Protein

2019· article· en· W2967876588 on OpenAlexaff
Justin R. Clark, Michael B. Boffa, Marlys L. Koschinsky

Bibliographic record

VenueArteriosclerosis Thrombosis and Vascular Biology · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer, Lipids, and Metabolism
Canadian institutionsRobarts Clinical TrialsWestern University
Fundersnot available
KeywordsKexinProprotein convertaseMicrosomal triglyceride transfer proteinSubtilisinSecretionApolipoprotein BPCSK9Apolipoprotein C2Cholesterylester transfer proteinTriglycerideChemistryEndocrinologyBiochemistryInternal medicineBiologyLDL receptorLipoproteinVery low-density lipoproteinMedicineCholesterolEnzyme

Abstract

fetched live from OpenAlex

Elevated plasma lipoprotein(a) (Lp(a)) levels are the most prevalent inherited risk factor for CVD, but development of specific Lp(a) lowering therapeutics has been hindered by a lack of fundamental understanding of Lp(a) biology. In this study, we used an in vitro model to assess if the secretion of apo(a) is regulated by proteins known to modulate the cellular trafficking and metabolism of other lipoprotein classes. Genetic studies have identified an association between sortilin, a multi-ligand sorting receptor, with plasma Lp(a)-cholesterol concentrations. Monoclonal antibody inhibitors of PCSK9, used to treat elevated plasma LDL-cholesterol, also reduce Lp(a). Lomitapide is used to treat elevated plasma LDL-cholesterol and also appears to reduce Lp(a) levels. In each of these cases, the mechanisms involved are unclear or unknown. In this study, HepG2 (human hepatoma) cells expressing a 17-Kringle (17K) apo(a) isoform were (1) transiently transfected with empty vector control, wild-type (WT) sortilin, or different human sortilin polymorphic variants; (2) exposed to 20 μg/mL of PCSK9; or (3) treated with Lomitapide, an MTP inhibitor. Apo(a) and apoB100 secretion was measured by pulse-chase analysis. . Overexpression of WT sortilin significantly increased the secretion of both apo(a) (89%) and apoB100 (152%) relative to control (both p<0.05). Importantly, sortilin overexpression decreased apoB100 secretion in cells lacking apo(a) co-expression, as previously shown. Expression of the sortilin variants F404Y, K302E and V650M significantly increased secretion of apo(a) compared to WT (by a further 118%, 112% and 125% respectively; p<0.05). Treating 17K-expressing HepG2 cells with 20 μg/mL PCSK9 significantly increased (90%; p<0.05) apo(a) secretion versus control. Interestingly, this effect was dependent on the presence of the lysine binding sites in apo(a) required for non-covalent binding to apoB-100. Finally, treating 17K-expressing HepG2 cells with 20 nM lomitapide significantly reduced (by 64%; p<0.05) the secretion of apo(a). Our findings suggest roles for sortilin, PCSK9, and MTP in modulating Lp(a) levels through effects on apo(a) secretion, possibly through impacts on the secretion or bioavailability of apoB100.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.241
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueArteriosclerosis Thrombosis and Vascular BiologySame topicCancer, Lipids, and MetabolismFrench-language works237,207